M. Ryberg
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
-
- Chemotherapy-induced cardiotoxicity and mitigation
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 6
- Lung Cancer Research Studies 3
-
- Chemotherapy-induced cardiotoxicity and mitigation 6
- Co-authors
- P DombernowskyTorben SkovsgaardDorte NielsenBenny Vittrup JensenJosie HansenGerald BatistRobert LeonardPierre Soubeyran
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Journal of Internal Medicine (1 paper)Heliyon (1 paper)Upsala Journal of Medical Sciences (1 paper)
- Partner nations
- DenmarkSwedenUnited Kingdom
In The Last Decade
M. Ryberg
12 papers receiving 463 citations
Peers
Comparison fields: 5 of 69
- Oncology 268
- Cardiology and Cardiovascular Medicine 221
- Cancer Research 74
- Pulmonary and Respiratory Medicine 126
- Geriatrics and Gerontology 11
Countries citing papers authored by M. Ryberg
This map shows the geographic impact of M. Ryberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ryberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ryberg more than expected).
Fields of papers citing papers by M. Ryberg
This network shows the impact of papers produced by M. Ryberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ryberg. The network helps show where M. Ryberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Ryberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2010 | 111 | |
| 3 | 2010 | 2 | |
| 4 | 2008 | 0 | |
| 5 | 2007 | 1 | |
| 6 | 2005 | 7 | |
| 7 | 2001 | 46 | |
| 8 | 1998 | 223 | |
| 9 | 1994 | 29 | |
| 10 | 1990 | 4 | |
| 11 | 1990 | 15 | |
| 12 | 1989 | 2 | |
| 13 | 1988 | 35 |
About M. Ryberg
M. Ryberg is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Dermatology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 13 papers that have together received 479 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Cancer Treatment and Pharmacology (6 papers), Lung Cancer Research Studies (3 papers), Breast Cancer Treatment Studies (2 papers), Chemotherapy-related skin toxicity (2 papers), Glycosylation and Glycoproteins Research (1 paper), Advanced Breast Cancer Therapies (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). The work is most often cited by research in Oncology (268 citations), Cardiology and Cardiovascular Medicine (221 citations), Cancer Research (74 citations), Pulmonary and Respiratory Medicine (126 citations) and Geriatrics and Gerontology (11 citations). M. Ryberg has collaborated with scholars based in Denmark, Sweden and United Kingdom. Frequent co-authors include P Dombernowsky, Torben Skovsgaard, Dorte Nielsen, Benny Vittrup Jensen, Josie Hansen, Gerald Batist, Robert Leonard, Pierre Soubeyran, Aňa Lluch and Étienne Brain. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Internal Medicine, Heliyon and Upsala Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.